Leios/Alesse
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Contraceptives, Oral, Combined
Conditions
Contraceptives, Oral, Combined
Trial Timeline
May 1, 2005 → Mar 1, 2007
NCT ID
NCT00481650About Leios/Alesse
Leios/Alesse is a pre-clinical stage product being developed by Pfizer for Contraceptives, Oral, Combined. The current trial status is completed. This product is registered under clinical trial identifier NCT00481650. Target conditions include Contraceptives, Oral, Combined.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00481650 | Pre-clinical | Completed |
Competing Products
4 competing products in Contraceptives, Oral, Combined
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| AZD1981 + Neovletta 21/28 + Placebo AZD1981 | AstraZeneca | Phase 1 | 33 |
| EV/DNG (Qlaira, BAY86-5027) + Progestin Only Pills | Bayer | Pre-clinical | 20 |
| YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) + Yasminelle (SH T 00186 D) | Bayer | Phase 2 | 49 |
| Levonorgestrel Emergency Pill (BAY86-5028) + Postinor 2 | Bayer | Phase 1 | 30 |